Abstract
The clinical actions of antipsychotic drugs (APDs) have typically been attributed to their effects on dopaminergic systems in the brain. Despite the controversy regarding whether or not blockade of dopamine (DA) receptors is both necessary and sufficient for APDs to exert their therapeutic actions, it is evident that the mesolimbic and/or mesocortical DA systems play some role in the clinical efficacy of these drugs. Similarly, the development of motor side effects following long-term treatment with classical neuroleptics appears to be contingent on their actions on the motor-related nigrostriatal DA projection. The focus of this chapter will be on reviewing studies of the physiology of DA systems as it relates to APD action, with particular emphasis on DA cell firing, how it is generated, how it is controlled, and how long-term treatment with APDs can lead to its inactivation, a condition known as depolarization block. In addition, this chapter will encompass recently described actions of APDs as they involve the modulation of information processing at a network level within structures receiving dopaminergic input (i.e., the striatum and nucleus accumbens). Briefly, it is now known that the ability of DA to modulate electrical coupling between neurons in these structures can be modified by long-term treatment with APDs. Thus, the actions of APDs within the basal ganglia appear to be rather complex, and several levels of analyses must be synthesized in order to gain a more comprehensive perspective of their actions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abercrombie ED, Hollerman JR, Grace AA (1989) In vivo biochemical correlates of acute depolarization inactivation in substantia nigra dopaminergic neurons. Soc Neurosci Abstr 15:1002
Ackerman JM, Johansen PA, Clark D, White FJ (1993) Electrophysiological effects of putative autoreceptor-selective dopamine agonists on A10 dopamine neurons. J Pharmacol Exp Ther 265:963–970
Andrew RD, MacVicar BA, Dudek FE, Hatton GI (1981) Dye transfer through gap junctions between neuroendocrine cells on rat hypothalamus. Science 211:1187- 1189
Angrist B, van Kammen DP (1984) CNS stimulants as tools in the study of schizophrenia. Trends Neurosci 388-390
Angrist B, Shopin B, Gershon S (1971) Comparative psychotomimetic effects of stereoisomers of amphetamine. Nature 234:152–153
Angrist B, Santhananthan G, Wilk S, Gershon S (1974) Amphetamine psychosis:behavioral and biochemical aspects. J Psychiatr Res 11:13–23
Arnold SE, Hyman BT, Van Hoesen GW, Damasio AR (1991) Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 48:625–632
Asencio H, Bustos G, Gysling K, Labarca R (1991) N-Methyl-D-aspartate receptors and release of newly-synthesized [3H]dopamine in nucleus accumbens slices and its relationship with neocortical afferents. Prog Neuropsychopharmacol Biol Psychiatry 15:663–676
Barta PE, Pearlson GD, Powers RE, Richards SS, Tune LE (1990) Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatry 147:1457–1462
Berman KF, Zee RF, Weinberger DR (1986) Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort. Arch Gen Psychiatry 43:126–135
Blaha CD, Lane RF (1987) Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivo. Neurosci Lett 78:199–204
Bogerts B, Lieberman JA, Ashtari M, Bilder RM, Degreef G, Lerner G, Johns C, Masiar S (1993) Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia. Biol Psychiatry 33:236–246
Bouyer JJ, Park DH, Joh TH, Pickel VM (1984) Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum. Brain Res 302:267–275
Bowery B, Rothwell LA, Seabrook GR (1994) Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area. Br J Pharmacol 112:873–880
Brodie MS, Dunwiddie TV (1987) Cholecystokinin potentiates dopamine inhibition of mesencephalic dopamine neurons in vitro. Brain Res 425:106–113
Buchsbaum MS, Ingvar DH, Kessler R, Waters RN, Cappelletti J, van Kammen DP, King C, Johnson JL, Manning RG, Flynn RW, Mann LS, Bunney WE, Sokoloff L (1982) Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia. Arch Gen Psychiatry 39:251–259
Bunney BS, Aghajanian GK (1975) Antipsychotic drugs and central dopaminergic neurons: a model for predicting therapeutic efficacy and the incidence of extrapyramidal side effects. In: Sudilovsky A, Gershon S, Beer B (eds) Predictability in psychopharmacology: preclinical and clinical correlates. Raven, New York, pp 225–245
Bunney BS, Grace AA (1978) Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity. Life Sei 23:1715–1728
Bunney BS, Walters JR, Roth RH, Aghajanian GK (1973) Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther 185:560–571
Cai N-S, Kiss B, Erdo SL (1991) Heterogeneity of N-methyl-D-aspartate receptors regulating the release of dopamine and acetylcholine from striatal slices. J Neurochem 57:2148–2151
Calabresi P, Mercuri N, Stanzione P, Stefani A, Bernardi G (1987) Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: evidence for Dx receptor involvement. Neuroscience 20:757–771
Carlsson A, Lindqvist M (1963) Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 20:140–144
Carpenter WT, Buchanan RW (1994) Schizophrenia. N Engl J Med 330:681–690
Carrozza DP, Ferraro TN, Golden GT, Reyes PF, Hare TA (1991) Partial characterization of kainic acid-induced striatal dopamine release using in vivo microdialysis. Brain Res 543:69–76
Carrozza DP, Ferraro TN, Golden GT, Reyes PF, Hare TA (1992) In vivo modulation of excitatory amino acid receptors: microdialysis studies on Af-methyl-D-aspar- tate-evoked striatal dopamine release and effects of antagonists. Brain Res 574:42–48
Carter CJ, L‚Heurex R, Scatton B (1988) Differential control by N-methyl-D-aspartate and kainate of striatal dopamine release in vivo: a trans-striatal study. J Neurochem 51:462–468
Cepeda C, Walsh JP, Hull CD, Howard SG, Buchwald NA, Levine MS (1989) Dye- coupling in the neostriatum of the rat. I. Modulation by dopamine-depleting lesions. Synapse 4:229–237
Chen J, Paredes W, Gardner EL (1991) Chronic treatment with clozapine selectively decreases basal dopamine release in nucleus accumbens but not in caudate- putamen as measured by in vivo brain microdialysis: further evidence for depolarization block. Neurosci Lett 122:127–131
Cheramy A, Romo R, Godeheu G, Baruch P, Glowinski J (1986) In vivo presynaptic control of dopamine release in the cat caudate nucleus - II. Facilitatory or inhibitory influence of L-glutamate. Neuroscience 19:1081–1090
Chergui K, Charlety PJ, Akaoka H, Saunier CF, Brunei J-L, Buda M, Svensson T, Chouvet G (1993) Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo. Eur J Neurosci 5:137- 144
Chergui K, Akaoka H, Charlety PJ, Saunier CF, Buda M, Chouvet G (1994) Subthalamic nucleus modulates burst firing of nigral dopamine neurones via NMDA receptors. Neuroreport 5:1185–1188
Chiodo LA (1988) Dopamine-containing neurons in the mammalian central nervous system: Electrophysiology and pharmacology. Neurosci Biobehav Rev 12:49–91
Chiodo LA (1992) Dopamine autoreceptor signal transduction in the DA cell body: a ‘current view’. Neurochem Int 20 [Suppl]:81S-84S
Chiodo LA, Bunney BS (1983) Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci 3:1607–1619
Chiodo LA, Bunney BS (1985) Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons. J Neurosci 5:2539–2544
Chiodo LA, Kapatos G (1992) Membrane properties of identified mesencephalic dopamine neurons in primary dissociated cell culture. Synapse 11:294–309
Clow DW, Jhamandas K (1989) Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen. J Pharmacol Exp Ther 248:722–728
Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:596–598
Csernansky JG, Bellows EP, Barnes DE, Lombrozo L (1990) Sensitization to the dopamine turnover-elevating effects of haloperidol: the effect of regular-intermittent dosing. Psychopharmacology 101:519–524
Csernansky JG, Murphy GM, Faustman WO (1991) Limbic/mesolimbic connections and the pathogenesis of schizophrenia. Biol Psychiat 30:383–400
Csernansky JG, Wrona CT, Bardgett ME, Early TS, Newcomer JW (1993) Subcortical dopamine and serotonin turnover during acute and subchronic administration of typical and atypical neuroleptics. Psychopharmacology 110:145–151
Cummings JL (1992) Neuropsychiatry complications of drug treatment of Parkinson’s disease. In: Huber SJ, Cummings JL (eds) Parkinson’s disease. Neurobehavioral aspects. Oxford University Press, New York, pp 313–327
Davis KL, Kahn RS, Ko G, Davidson M (1991) Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148:1474–1486
Dermietzel R, Spray DC (1993) Gap junctions in the brain: where, what type, how many and why? Trends Neurosci 16:186–192
Deutch AY, Roth RH (1988) Alterations in dopamine synthesis induced by chronic neuroleptic administration: a possible biochemical correlate of depolarization in- activation. Soc Neurosci Abstr 14:27
Deutch AY, Moghaddam B, Innis RB, Krystal JH, Aghajanian GK, Bunney BS, Charney DS (1991) Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia. Schizophr Res 4:121- 156
Deutch AY, Lee MC, Iadarola MJ (1992) Regionally specific effects of atypical antipsychotic drugs on striatal fos expression: the nucleus accumbens shell as a locus of antipsychotic action. Mol Cell Neurosci 3:332–341
Doherty MD, Gratton A (1991) Behavioral evidence of depolarization block of mesencephalic dopamine neurons by acute haloperidol in partially 6-hydroxydopamine lesioned rats. Behav Neurosci 105:579–587
Dudek FE, Snow RW (1985) Electrical interactions and synchronization of cortical neurons: electrotonic coupling and field effects. In: Bennet MVL, Spray DC (eds) Gap junctions. Cold Spring Harbor Laboratories, Cold Spring Harbor, New York, pp 325–336
Engberg G, Kling-Petersen T, Nissbrandt H (1993) GABAB-receptor activation alters the firing pattern of dopamine neurons in the rat substantia nigra. Synapse 15:229- 238
Evenden JL, Robbins TW (1983) Increased response switching, perseveration, and perseverative switching following ¿/-amphetamine in the rat. Psychopharmacology 80:67–73
Falkai P, Bogerts B (1986) Cell loss in the hippocampus of schizophrenics. Eur Arch Psychiatry Neurol Sci 236:154–161
Fey ET (1951) The performance of young schizophrenics and young normals on the Wisconsin Card Sorting Test. J Consult Psychol 15:311–319
Finlay JM, Jakubovic A, Fu S, Fibiger HC (1987) Tolerance to haloperidol-induced increases in dopamine and metabolites: fact or artifact? Eur J Pharmacol 137:117- 121
Freeman AS, Chiodo LA (1987) Electrophysiological aspects of cholecystokinin/ dopamine interactions in the central nervous system. Ann NY Acad Sci:205-236
French ED (1994) Phencyclidine and the midbrain dopamine system: electrophysiology and behavior. Neurotoxicol Teratol 16:355–362
Friston KJ (1992) The dorsolateral prefrontal cortex, schizophrenia and PET. J Neural Transm [Suppl] 37:79–93
Gariano RF, Groves PM (1988) Burst firing induced in midbrain dopamine neurons by stimulation of the medial prefrontal and anterior cingulate cortices. Brain Res 462:194–198
Gerlach J, Koppelhus P, Helweg E, Monrad A (1974) Clozapine and haloperidol in a single-blind cross-over trial: therapeutic and biochemical aspects in the treatment of schizophrenia. Acta Psychiat Scand 50:410–424
Gifford AN, Wang RY (1994) The effect of 5-HT3 receptor antagonists on the mor- phine-induced excitation of A10 dopamine cells: electrophysiological studies. Brain Res 638:325–328
Giorguieff MF, Kernel ML, Glowinski J (1977) Presynaptic effect of L-glutamic acid on the release of dopamine in rat striatal slices. Neurosci Lett 6:73–77
Goldberg TE, Bigelow LB, Weinberger DR, Daniel DG, Kleinman JE (1991) Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia. Am J Psychiatr 148:78–84
Goldstein JM, Litwin LC (1988) Spontaneous activity of A9 and A10 dopamine neurons after acute and chronic administration of the selective dopamine Dj receptor antagonist SCH23390. Eur J Pharmacol 155:175–180
Goldstein JM, Litwin LC, Sutton EB, Malick JB (1989) Effects of ICI 169,369, a selective serotonin-2 antagonist, in electrophysiological tests predictive of antipsychotic activity. J Pharmacol Exp Ther 249:673–680
Gonon FG (1988) Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience 24:19–28
Gonzalez Burgos GR, Biali FI, Cherksey BD, Sugimori M, Llinâs RR, Uchitel O (1995) Different calcium channels mediate transmitter release evoked by transient or sustained depolarization at mammalian sympathetic ganglia. Neuroscience 64:117–123
Grace AA (1987) The regulation of dopamine neuron activity as determined by in vivo and in vitro intracellular recordings. In: Chiodo LA, Freeman AS (eds) Neurophysiology of dopaminergic systems - current status and clinical perspectives. Lakeshore, Chicago, pp 1–66
Grace AA (1988) In vivo and in vitro intracellular recordings from rat midbrain dopamine neurons. Ann NY Acad Sci 537:51–76
Grace AA (1990) Evidence for the functional compartmentalization of spike generating regions of rat midbrain dopamine neurons recorded in vitro. Brain Res 524:31- 41
Grace AA (1991a) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41:1–24
Grace AA (1991b) Regulation of spontaneous activity and oscillatory spike firing in rat midbrain dopamine neurons recorded in vitro. Synapse 7:221–234
Grace AA (1992) The depolarization block hypothesis of neuroleptic action: implications for the etiology and treatment of schizophrenia. J Neural Transm [Suppl] 36:91–131
Grace AA, Bunney BS (1980) Nigral dopamine neurons: intracellular recording and identification using L-DOPA injection combined with fluorescence histochemistry. Science 210:654–656
Grace AA, Bunney BS (1983a) Intracellular and extracellular electrophysiology of nigral dopaminergic neurons - 1. Identification and characterization. Neuroscience 10:301–315
Grace AA, Bunney BS (1983b) Intracellular and extracellular electrophysiology of nigral dopaminergic neurons - 2. Action potential generating mechanisms and morphological correlates. Neuroscience 10:317–331
Grace A A, Bunney BS (1983c) Intracellular and extracellular electrophysiology of nigral dopaminergic neurons - 3. Evidence for electrotonic coupling. Neuroscience 10:333–348
Grace AA, Bunney BS (1984a) The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 4:2877–2890
Grace AA, Bunney BS (1984b) The control of firing pattern in nigral dopamine neurons: single spike firing. J Neurosci 4:2866–2876
Grace AA, Bunney BS (1986) Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording. J Pharmacol Exp Ther 238:1092–1100
Grace AA, Onn S-P (1989) Morphology and electrophysiological properties of immu- nocytochemically identified rat dopamine neurons recorded in vitro. J Neurosci 9:3463–3481
Gray JA, Feldon J, Rawlins JNP, Hemsley DR, Smith AD (1991) The neuropsychology of schizophrenia. Behav Brain Sci 14:1–84
Groves PM, Wilson CJ, Young SJ, Rebec GV (1975) Self-inhibition by dopaminergic neurons. Science 190:522–529
Gur RE, Pearlson GD (1993) Neuroimaging in schizophrenia research. Schizophrenia Bull 19:337–353
Gutnick MJ, Prince DA (1981) Dye coupling and possible electrotonic coupling in the guinea pig neocortical slices. Science 211:67–70
Harden DG, Grace AA (1994) Electrophysiological examination of feedback pathways to A9 and A10 dopamine neurons originating in the core and shell regions of the nucleus accumbens. Soc Neurosci Abstr 20:566
Harris NC, Greenfield SA (1991) The electrophysiological properties of substantia nigra pars compacta neurones recorded from 6-hydroxydopamine lesioned guinea-pigs in vitro. J Neural Transm [P-D Sect] 3:89–98
Heimer L, Zahm DS, Churchill L, Kalivas PW, Wohltmann C (1991) Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience 41:89- 125
Henry DJ, Wise RA, Rompre P-R, White FJ (1992) Acute depolarization block of A10 dopamine neurons: interactions of morphine with dopamine antagonists. Brain Res 596:231–237
Heritch A J (1990) Evidence for reduced and dysregulated turnover of dopamine in schizophrenia. Schizophr Bull 16:605–615
Hollerman JR, Grace AA (1989) Acute haloperidol administration induces depolarization block of nigral dopamine neurons in rats after partial dopamine lesions. Neurosci Lett 96:82–88
Hollerman JR, Grace AA (1990) The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons. Brain Res 533:203–212
Hollerman JR, Abercrombie ED, Grace A A (1992) Electrophysiological, biochemical, and behavioral studies of acute haloperidol-induced depolarization block of nigral dopamine neurons. Neuroscience 47:589–601
Hommer DW, Palkovits M, Crawley JN, Paul SM, Skirboll LR (1985) Cholecystokinin- induced excitation in the substantia nigra: evidence for peripheral and central components. J Neurosci 5:1387–1392
Hounsgaard J, Nedergaard S, Greenfield SA (1992) Electrophysiological localization of distinct calcium potentials at selective somatodendritic sites in the substantia nigra. Neuroscience 50:513–518
Hu X-T, Wang RY (1988) Comparison of effects of D1 and D2 dopamine receptor agonists on neurons in the rat caudate putamen: an electrophysiological study. J Neurosci 8:4340–4348
Ichikawa J, Meltzer HY (1992) The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo. Brain Res 574:98–114
Imperato A, DiChiara G (1985) Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis. J Neurosci 5:297- 306
Imperato A, Honore T, Jensen LH (1990) Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMD A receptors: a study in freely-moving rats. Brain Res 530:223–228
Innis RB, Aghajanian GK (1987) Pertussis toxin blocks autoreceptor-mediated inhibition of dopaminergic neurons in rat substantia nigra. Brain Res 411:139–143
Iversen LL (1975) Uptake processes for biogenic amines. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology. Plenum, New York, pp 381- 392
Iversen SD, Wilkinson S, Simpson B (1971) Enhanced amphetamine responses after frontal cortex lesions in the rat. Eur J Pharmacol 13:387
Iwatsubo K, Clouet DH (1977) Effects of morphine and haloperidol on the electrical activity of rat nigrostriatal neurons. J Pharmacol Exp Ther 202:429–436
Jaskiw GC, Karoum F, Freed WJ, Phillips I, Kleinman JE, Weinberger DR (1990) Effect of ibotenic acid lesions of the medial prefrontal cortex on amphetamine- induced locomotion and regional brain catecholamines concentrations in the rat. Brain Res 534:263–272
Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301–1308
Javitt DC, Zylberman I, Zukin SR, Heresco-Levy U, Lindenmayer J-P (1994) Amelioration of negative symptoms in schizophrenia by glycine. Am J Psychiatry 151:1234–1236
Jenkins RB, Groh RH (1970) Mental symptoms in parkinsonian patients treated withl-dopa. Lancet ii:177—179
Jiang LH, Tsai M, Wang RY (1988) Chronic treatment with high doses of haloperidol fails to decrease the time course for the development of depolarization inactiva- tion of midbrain dopamine neurons. Life Sci 43:75–81
Johnson JW, Ascher P (1987) Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325:529-531
Johnson KM, Jeng Y-J (1991) Pharmacological evidence for TV-methyl-D-aspartate receptors on nigrostriatal dopaminergic nerve terminals. Can J Physiol Pharmacol 69:1416–1421
Johnson SW, North RA (1992) Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J Physiol (Lond) 450:455–468
Johnson SW, Seutin V, North RA (1992) Burst firing in dopamine neurons induced by TV-methyl-D-aspartate: role of electrogenic pump. Science 258:665–667
Jones SM, Snell LD, Johnson KM (1987) Inhibition by phencyclidine of excitatory amino acid-stimulated release of neurotransmitter in the nucleus accumbens. Neuropharmacology 26:173–179
Kabzinski AM, Szewczak MR, Cornfeldt ML, Fielding S (1987) Differential effects of dopamine agonists and antagonists on the spontaneous electrical activity of A9 and A10 dopamine neurons. Soc Neurosci Abstr 13:908
Kalivas PW, Duffy P (1991) A comparison of axonal and somatodendritic dopamine release using in vivo dialysis. J Neurochem 56:961–967
Kamata K, Rebec GV (1984) Nigral dopaminergic neurons: differential sensitivity to apomorphine following long-term treatment with low and high doses of amphetamine. Brain Res 321:147–150
Kane J, Honigfeld G, Singer J, Meltzer H (1988) Clozapine for the treatment-resistant schizophrenic. Arch Gen Psychiatry 45:789–796
Karoum F, Chrapusta SJ, Egan MF (1994) 3-methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool mode. J Neurochem 63:972–979
Kawasaki Y, Maeda Y, Urata K, Higashima M, Yamaguchi N, Suzuki M, Takashima T, Ide Y (1993) A quantitative magnetic resonance imaging study of patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 242:268–272
Kebabian JW, Calne R (1979) Multiple receptors for dopamine. Nature 277:93–96
Keefe KA, Sved AF, Zigmond MJ, Abercrombie ED (1993) Stress-induced dopamine release in the neostriatum: evaluation of the role of action potentials in nigrostriatal dopamine neurons or local initiation by endogenous excitatory amino acids. J Neurochem 61:1943–1052
Kelland M, Chiodo LA, Freeman AS (1990) Anesthetic influences on the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons. Synapse 6:207–209
Kita H (1993) GABAergic circuits of the striatum. In: Arbuthnott GW, Emson PC (eds) Chemical signaling in the basal ganglia. Elsevier, Amsterdam, pp 51–72
Klawans HL, Margolin DI (1975) Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Arch Gen Psychiatry 32:725–732
Kovelman JA, Scheibel AB (1984) A neurohistological correlate of schizophrenia. Biol Psychiatry 19:1601–1917
Krebs M-O, Trovero F, Desban M, Gauchy C, Glowinski J, Kemel M-L (1991a) Distinct presynaptic regulation of dopamine release through NMDA receptors in striosome- and matrix-enriched areas of the rat striatum. J Neurosci 11:1256- 1262
Krebs M-O, Desee JM, Kemel ML, Gauchy C, Godeheu G, Chéramy A, Glowinski J (1991b) Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J Neurochem 56:81–85
Lacey MG, Mercuri NB, North RA (1987) Dopamine acts on D2 receptors to increase potassium conductance in neurons of the rat substantia nigra zona compacta. J Physiol (Lond) 392:397–416
Lahti AC, Laporte DJ, Mokciski B, Tamminga CA (1993) Effect of the NMDA antagonist ketamine in schizophrenic patients. Soc Neurosci Abstr 19:1351
Lane RF, Blaha CD (1987) Chronic haloperidol decreases dopamine release in striatum and nucleus accumbens in vivo: depolarization block as a possible mechanism of action. Brain Res Bull 18:135–138
Lavin A, Grace A A (1994) Modulation of dorsal thalamic cell activity by the ventral pallidum: its role in the regulation of thalamocortical activity by the basal ganglia. Synapse 18:104–127
Leviel V, Gobert A, Guibert B (1990) The glutamate-mediated release of dopamine in the rat striatum: further characterization the dual excitatory-inhibitory function. Neuroscience 39:305–312
Levine MS (1991) Dopamine modulates coupling in the striatum. In: Gap junction protein (connexin) and electrical synapses in the central nervous system. 3rd IBRO world congress of neuroscience, p W35
Lichtensteiger W, Felix D, Lienhart R, Hefti F (1976) A quantitative correlation between single unit activity and fluorescence intensity of dopamine neurones in zona compacta of substantia nigra, as demonstrated under the influence of nicotine and physostigmine. Brain Res 117:85–103
Liddle PF, Morris DL (1991) Schizophrenic syndromes and frontal lobe performance. Br J Psychiatry 158:340–345
Liddle PF, Friston KJ, Frith CD, Frachowiak RSJ (1992a) Cerebral blood flow and mental processes in schizophrenia. J R Soc Med 85:224–227
Liddle PF, Friston KJ, Frith CD, Hirsch SR, Jones T, Frachowiak RSJ (1992b) Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry 160:179–186
Liu L, Shen R-Y, Kapatos G, Chiodo LA (1994) Dopamine neuron membrane physiology: characterization of the transient outward current (IA) and demonstration of a common signal transduction pathway for IA and IK. Synapse 17:230–240
MacGibbon GA, Lawlor PA, Bravo R, Dragunow M (1994) Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate- putamen, nucleus accumbens, lateral septum and islands of Calleja. Mol Brain Res 23:21–32
Martínez-Fong D, Rosales MG, Góngora-Alfaro JL, Hernández S, Aceves J (1992) NMDA receptor mediates dopamine release in the striatum of unanesthetized rats as measured by brain microdialysis. Brain Res 595:309–315
Matsumoto A, Arai Y, Urano A, Hyodo S (1991) Cellular localization of gap junction mRNA in the neonatal rat brain. Neurosci Lett 124:225–228
Matthysse S (1978) A theory of the relation between dopamine and attention. In: Wynne LC, Cromwell RL, Matthysse S (eds) The nature of schizophrenia. New approaches to research and treatment. Wiley, New York, pp 307–310
Meltzer LT, Christoffersen CL, Heffner TG, Freeman AS, Chiodo LA (1989) CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity. J Pharmacol Exp Ther 251:123–130
Merchant KM, Dorsa DM (1993) Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics. Proc Natl Acad Sci USA 90:3447–3451
Mercuri NB, Stratta F, Calabresi P, Bernardi G (1992) A voltage-clamp analysis of NMDA-induced responses on dopaminergic neurons of the rat substantia nigra zona compacta and ventral tegmental area. Brain Res 593:51–56
Mercuri NB, Stratta F, Calabresi P, Bernardi G (1993) Neurotensin induces an inward current in rat mesencephalic dopaminergic neurons. Neurosci Lett 153:192–196
Mereu G, Casu M, Gessa GL (1983) (-) Sulpiride activates the firing rate and tyrosine hydroxylase activity of dopaminergic neurons in unanesthetized rats. Brain Res 264:105–110
Mereu G, Fanni B, Gessa GL (1984) General anesthetics prevent dargic neuron stimulation by neuroleptics. In: Usdin E, Carlsson A, Dahlstrom F, Engel J (eds) Catecholamines, neuropharmacology and central nervous system, theoretical aspects. Liss, New York, p 353
Mereu G, Lilliu V, Vargiu P, Muntoni AL, Diana M, Gessa GL (1994) Failure of chronic haloperidol to induce depolarization inactivation of dopamine neurons in unanesthetized rats. Eur J Pharmacol 264:449–453
Miller JD, Sanghera MK, German DC (1981) Mesencephalic dopaminergic unit activity in the behaviorally conditioned rat. Life Sci 29:1255–1263
Moghaddam B, Bolinao ML (1994) Glutamatergic antagonists attenuate ability of dopamine uptake blockers to increase extracellular levels of dopamine: implications for tonic influence of glutamate on dopamine release. Synapse 18:337–342
Moghaddam B, Gruen R, Roth RH, Bunney BS, Adams RN (1990) Effect of L- glutamate on the release of striatal dopamine: in vivo dialysis and electrochemical studies. Brain Res 518:55–60
Mueller AL, Brodie MS (1989) Intracellular recording from putative dopamine-con- taining neurons in the ventral tegmental area of Tsai in a brain slice preparation. J Neurosci Methods 28:15–22
Murase S, Grenhoff J, Chouvet G, Gonon F, Svensson T (1993) Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci Lett 157:53–56
Nguyen TV, Kosofsky BE, Birnbaum R, Cohen BM, Hyman SE (1992) Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc Natl Acad Sci U S A 89:4270–4274
Nieoullon A, Cheramy A, Glowinski J (1978) Release of dopamine evoked by electrical stimulation of the motor and visual areas of the cerebral cortex in both caudate nuclei and in the substantia nigra in the cat. Brain Res 145:69–83
Nisenbaum ES, Berger TW, Grace AA (1993) Depression of glutamatergic and GABAergic synaptic responses in striatal spiny neurons by stimulation of presynapticGABA b receptors. Synapse 14:221–242
Nissbrandt H, Elverfors, A, Engberg G (1994) Pharmacologically induced cessation of burst activity in nigral dopamine neurons: significance for the terminal dopamine efflux. Synapse 17:217–224
Nunez A, Garcia-Austt E and Buno W (1990) In vivo electrophysiological analysis of Lucifer yellow-coupled hippocampal pyramids. Exp Neurol 108:76–82
O’Donnell P, Grace AA (1993) Dopaminergic modulation of dye coupling between neurons in the core and shell regions of the nucleus accumbens. J Neurosci 13:3456–3471
O’Donnell P, Grace AA (1994) Tonic D2-mediated attenuation of cortical excitation in nucleus accumbens neurons recorded in vitro. Brain Res 634:105–112
O’Donnell P, Grace AA (1995a) Different effects of subchronic clozapine and haloperidol on dye coupling between neurons in the rat striatal complex. Neuro- science 66:763–767
O’Donnell P, Grace AA (1995b) Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input. J Neurosci 15:3622–3639
Onn S-P, Grace AA (1993) Effects of dopamine depletion on dye- and tracer-coupling between spiny cells and between aspiny cells in striatum. Soc Neurocsi Abstr 19:997
Onn S-P, Grace AA (1994a) Dye coupling between rat striatal neurons recorded in vivo: compartmental organization and modulation by dopamine. J Neurophysiol 71:1917–1934
Onn S-P, Grace AA (1994b) Repeated treatment with typical and atypical neuroleptics enhances electrotonic neurotransmission in the ventral corticostriatal regions. Soc Neurosci Abstr 20:565
Overton P, Clark D (1992) Iontophoretically administered drugs acting at the N- methyl-D-aspartate receptor modulate burst firing in A9 dopamine neurons in the rat. Synapse 10:431–440
Paskevich PA, Evans KH, Domesick VB (1991) Morphological assessment of neuronal aggregates in the striatum of the rat. J Comp Neurol 305:361–369
Peinado A, Yuste R, Katz LC (1993) Extensive dye coupling between rat neocortical neurons during the period of circuit formation. Neuron 10:103–114
Pettegrew JW, Keshavan M, Panchalingbam K, Strychor S, Kaplan DB, Tretta MG, Allen M (1991) Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. Arch Gen Psychiatry 48:563–568
Pickar D, Labarca R, Linnoila M, Roy A, Hommer D, Everett D, Paul SM (1984) Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients. Science 225:954–957
Post RM, Fink E, Carpenter WT, Goodwin FK (1975) Cerebrospinal fluid amine metabolites in acute schizophrenia. Arch Gen Psychiatry 32:1063–1069
Pucak ML, Grace AA (1991) Partial dopamine depletions result in an enhanced sensitivity of residual dopamine neurons to apomorphine. Synapse 9:144–155
Pucak ML, Grace AA (1994) Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors. J Pharmacol Exp Ther 271:1181–1192
Raine A, Lencz T, Reynolds GP, Harrison G, Sheard C, Medley I, Reynolds LM, Cooper JE (1992) An evaluation of structural and functional prefrontal deficits in schizophrenia: MRI and neuropsychological measures. Psychiatry Res Neuro- imaging 45:123–137
Riederer P Wuketich S (1976) Time course of nigrostriatal degeneration in Parkinson’s disease. J Neural Transm 38:277–301
Robbins TW (1990) The case for frontostriatal dysfunction in schizophrenia. Schizophr Bull 16:391–402
Roberts PJ Anderson SD (1979) Stimulatory effect of L-glutamate and related amino acids on [3H] dopamine release from rat striatum: an in vitro model for glutamate actions. J Neurochem 32:1539–1545
Robertson GS, Fibiger HC (1992) Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience 46:315- 328
Rompre P-P, Wise RA (1989) Behavioral evidence for midbrain dopamine neuron depolarization block. Brain Res 477:152–156
Sanghera MK, Trulson ME, German DC (1984) Electrophysiological properties of mouse dopamine neurons: in vivo and in vitro studies. Neuroscience 12:793- 801
Santiago M, Westerink BHC (1991) Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats. J Neurochem 57:738–747
Santiago M, Westernik BHC (1992) Simultaneous recording of the release of nigral and striatal dopamine in the awake rat. Neurochem Int 20 [Suppl]:107S-110S
Schwartz J-C, Sokoloff P, Giros B, Martres MP, Bouthenet ML (1992) The dopamine D3 receptor as a target for antipsychotics. In: Meltzer HY (ed) Novel antipsychotic drugs. Raven, New York, pp 135–144
Sedvall G, Farde L, Persson A, Weisel FA (1986) Imaging of neurotransmitter receptors in the living human brain. Arch Gen Psychiatry 43:995–1006
Seeman P (1987) Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1:113–152
Sesack SR, Pickel VM (1990) In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other. Brain Res 527:266–279
Sesack SR, Pickel VM (1992) Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J Comp Neurol 320:145- 160
Sesack Sr, Aoki C, Pickel VM (1994) Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J Neurosci 14:88–106
Seutin V, Verbank P, Massotte L, Dresse A (1990) Evidence for the presence of N- methyl-D-aspartate receptors in the ventral tegmental area of the rat: an electrophysiological in vitro study. Brain Res 514:147–150
Seutin V, Johnson SW, North RA (1993) Apamin increases NMDA-induced burstfiring of rat mesencephalic dopamine neurons. Brain Res 630:341–344
Shen R-Y, Altar CA, Chiodo LA (1994) Brain-derived neurotrophic factor increases the electrical activity of pars compacta dopamine neurons in vivo. Proc Natl Acad Sci USA 91:8920–8924
Shenton ME, Kikinis R, Jolesz FA, Pollak SD, LeMay M, Wible CG, Hokama H, Martin J, Matcalf D, Coleman M, McCarley RW (1992) Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study. N Engl J Med 327:604–612
Shepard PD, Bunney BS (1991) Repetitive firing properties of putative dopamine- containing neurons in vitro: regulation by an apamin-sensitive Ca2+-activated K+ conductance. Exp Brain Res 86:141–150
Sherman AD, Davidson AT, Baruah S, Hegwood TS, Waziri R (1991) Evidence of glutamatergic deficiency in schizophrenia. Neurosci Lett 121:77–80
Shi W-X, Bunney BS (1992) Roles of intracellular cAMP and protein kinase A in the actions of dopamine and neurotensin on midbrain dopamine neurons. J Neurosci 12:2433–2438
Shimizu N, Duan S, Hori T, Oomura Y (1990) Glutamate modulates dopamine release in the striatum as measured by brain microdialysis. Brain Res Bull 25:99–102
Skarsfeldt T (1988) Differential effects after repeated treatment with haloperidol, clozapine, thioridazine, and tefludazine on SNC and VTA dopamine neurons in rats. Life Sci 42:1037–1044
Skarsfeldt T (1993) Comparison of the effect of substituted benzamides on midbrain dopamine neurones after treatment of rats for 21 days. Eur J Pharmacol 240:269- 275
Skarsfeldt T (1994) Comparison of short-term administration of sertindole, clozapine and haloperidol on the inactivation of midbrain dopamine neurons in the rat. Eur J Pharmacol 254:291–294
Smith ID, Grace A A (1992) Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity. Synapse 12:287–303
Snyder SH (1972) Catecholamines in the brain as mediators of amphetamine psychosis.Arch Gen Psychiat 27:169–179
Snyder SH (1973) Amphetamine psychosis: a model of schizophrenia mediated by catecholamines. Am J Psychiatry 130:61–67
Sorensen SM, Humphreys TM, Palfreyman MG (1989) Effect of acute and chronic MDL 73147EF, a 5-HT3 receptor antagonist, on A9 and A10 dopamine neurons. Eur J Pharmacol 1163:115–118
Sotelo C, Korn H (1978) Morphological correlates of electrical and other interactions through low-resistance pathways between neurons of the vertebrate central nervous system. Int Rev Citol 55:67–107
Stewart WW (1981) Lucifer dyes. Highly fluorescent dyes for biological tracing. Nature 292:17–21
Suaud-Chagny MF, Chergui K, Chouvet G, Gonon F (1992) relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area. Neuroscience 49:63–72
Suddath RL, Christison GW, Torrey EF, Casanova MF, Weinberger DR (1990) Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N Engl J Med 322:789–794
Szewczak MR, Dunn RW, Corbett R, Geyer HM, Rush DK, Wilker JC, Strupczewski JT, Helsely GC, Cornfeldt ML (1990) The in vivo pharmacology of the novel antipsychotic HP 873. Soc Neurosci Abstr 16:249
Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase TN, Carpenter WT (1992) Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 49:522–530
Tepper JM, Nakamura S, Young ST, Groves PM (1984) Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of striatal drug infusions. Brain Res 309:317–333
Todorova A, Dimpfel W (1994) Multiunit activity from the A9 and A10 areas in rats following chronic treatment with different neuroleptic drugs. Eur J Neuro- psychopharmacol 4:491–501
Tung CS, Grenhoff J, Svensson T (1991) Kynurenate blocks the acute effects of haloperidol on midbrain dopamine neurons recorded in vivo. J Neural Transm 84:53–64
van Bockstaele EJ, Sesack SR, Pickel VM (1994a) Dynorphin-immunoreactive terminals in the rat nucleus accumbens: cellular sites for modulation of target neurons and interactions with catecholamine afferents. J Comp Neurol 341:1–15
van Bockstaele EJ, Gracy KN, Pickel VM (1994b) Ultrastructure of dynorphine immu- noreactive perikarya and terminals in the nucleus accumbens: relations to dopamine and substance P. Soc Neurosci Abstr 20:1733
van Kämmen DP, Bok van Kammen W, Mann LS, Seppala T, Linnoila M (1986) Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy. Arch Gen Psychiatry 43:978–983
Wachtel ST, White FJ (1992) The effect of continuous and repeated administration of D1 dopamine receptor antagonist on midbrain dopamine neurons. Neurochem Int 20 [Suppl]:129S-133S
Waddington JL (1993) Schizophrenia: developmental neuroscience and pathobiology. Lancet 341:531–536
Walsh JP, Cepeda C, Hull CD, Fisher RS, Levine MS, Buchwald NA (1989) Dye- coupling in the neostriatum of the rat: II. Decreased coupling between neurons during development. Synapse 4:238–247
Walsh JP, Cepeda C, Buchwald NA, Levine MS (1991) Neurophysiological maturation of cat substantia nigra neurons: evidence from in vitro studies. Synapse 7:291–300
Wang JKT (1991) Presynaptic glutamate receptors modulate dopamine release from striatal synaptosomes. J Neurochem 57:819–822
Wang T, French ED (1993a) Effects of phencyclidine on spontaneous and excitatory amino acid-induced activity of ventral tegmental dopamine neurons: an extracellular in vitro study. Life Sei 53:49–56
Wang T, French ED (1993b) L-glutamate excitation of A10 dopamine neurons is preferentially mediated by activation of NMD A receptors: extra- and intracellular electrophysiological studies in brain slices. Brain Res 627:299–306
Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660–669
Weinberger DR, Berman KF, Suddath R, Torrey EF (1992) Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. Am J Psychiatry 149:890–897
White FJ, Wang RY (1983) Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science 221:1054–1057
Wolkin A, Sanfilipo M, Wolf AP, Angrist B, Brodie JD, Rotrosen J (1992) Negative symptoms and hypofrontality in chronic schizophrenia. Arch Gen Psychiatry 49:959–965
Wolkin A, Sanfilipo M, Angrist B, Duncan E, Wieland S, Wolf AP, Brodie JD, Cooper TB, Laska E, Rotrosen JP (1994) Acute d-amphetamine challenge in schizophrenia: effects on cerebral glucose utilization and clinical symptomatology. Biol Psychiatry 36:317–325
Woodruff GN, McCarthy PS, Walker RJ (1976) Studies on the pharmacology of neurones in the nucleus accumbens of the rat. Brain Res 115:233–242
Wu H-Q, Schwarcz R, Shepard PD (1994) Excitatory amino acid-induced excitation of dopamine-containing neurons in the rat substantia nigra: modulation by kynurenic acid. Synapse 16:219–230
Wyatt RJ (1986) The dopamine hypothesis: variations on a theme (II). Psychopharmacol Bull 22:923–927
Wyatt RJ, Alexander RC, Egan MF, Kirch DG (1988) Schizophrenia, just the facts. What do we know, how well do we know it? Schizophr Res 1:3–18
Youngren KD, Daly DA, Moghaddam B (1993) Distinct actions of endogenous excitatory amino acids on the outflow of dopamine in the nucleus accumbens. J Pharmacol Exp Ther 264:289–293
Yung WH, Hausser MA, Jack JJB (1991) Electrophysiology of dopaminergic and non- dopaminergic neurones of the guinea-pig substantia nigra pars compacta in vitro. J Physiol (Lond) 436:643–667
Zetterstrom T, Sharp T, Ungerstedt U (1985) Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis. Eur J Pharmacol 106:27–37
Zhang H, Kiyatkin EA, Stein EA (1994) Behavioral and pharmacological modulation of ventral tegmental dendritic dopamine release. Brain Res 656:59–70
Zieglgansberger W, Puil EA (1983) Actions of glutamic acid on spinal neurones. Exp Brain Res 17:35–49
Zigmond MJ, Abercrombie ED, Berger TW, Grace AA, Strieker EM (1990) Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci 13:290–296
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
O‚Donnell, P., Grace, A.A. (1996). Basic Neurophysiology of Antipsychotic Drug Action. In: Csernansky, J.G. (eds) Antipsychotics. Handbook of Experimental Pharmacology, vol 120. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-61007-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-61007-3_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64653-9
Online ISBN: 978-3-642-61007-3
eBook Packages: Springer Book Archive